characteristics.text: SAMN48677767
characteristics.characteristic: External Id
characteristics.text: Boston Childrens Hospital
characteristics.characteristic: INSDC center name
characteristics.text: 2025-11-18T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-11-18T15:11:05.223Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS25117003
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS25117003
characteristics.characteristic: SRA accession
characteristics.text: MEC-1 cells
characteristics.characteristic: cell line
characteristics.text: Human chronic lymphocytic leukemia (CLL) cell line
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: AID_WT
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: MEC-1 cells
characteristics.characteristic: source_name
characteristics.text: MEC-1 AID-WT Idelalisib
characteristics.characteristic: title
characteristics.text: Tazemetostat/Valemetostat
characteristics.characteristic: treatment